Agilent Technologies Inc. (A)
NYSE: A · Laboratory Analytical Instruments · Santa Clara, CA · filing with the SEC since 1999
Grade6.2
◀ Past 6.8● Present 6.0▶ Future 5.7
Who owns Agilent Technologies Inc.
As filed with the SECHolders of 5% or more
3
Blackrock, Inc. holds 8.3% of Common Stock, as its SCHEDULE 13G/A filed Apr 17, 2025 says.
Directors and officers
22
report now, of 39 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 28, 2026 · Common Stock
Massachusetts Financial Services Company
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What A reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Resolution Bioscience, Inc.
A company bought · acquisition · owns, named in the 10-K filed Dec 22, 2025
12 subsidiaries in 7 countries, from the list filed with the 10-K filed Dec 22, 2025.
Insider tradesForm 4
6sales
0purchases
2sales on a scheduled plan
3people selling
$3.2Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 39 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Mcdonnell Padraig | President and CEO | 2 | $2.0M | 2 | 0 | $0 |
| Dolsten Mikael | director | 3 | $700,000 | 0 | 0 | $0 |
| Gonsalves Rodney | V.P., Corporate Controller | 1 | $500,000 | 0 | 0 | $0 |